FDA Panel Rejects Protein Sciences Corporation’s Cell Culture Flu Vaccine, Wants More Safety Data

Bookmark and Share

Reuters -- More safety data would be needed before a new type of influenza vaccine made in insect cells should get approval, federal advisers said on Thursday.

MORE ON THIS TOPIC